Jubilant Cadista Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Jan 15, 2025
  • 2 Class I recalls
  • No warning letters matched by name
Inspections 9 0 OAI
Recalls 31 2 Class I (6%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Jubilant Cadista Pharmaceuticals, Inc. has 31 FDA recalls (2 Class I), 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Jubilant Cadista Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "Jubilant Cadista Pharmaceuticals, Inc." and its spelling variant "Jubilant Cadista Pharmaceuticals".

Latest recall
D-0096-2023 · Class III · Dec 27, 2022
Latest inspection
Jan 15, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls31 (2 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Jubilant Cadista Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Jubilant Cadista Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 5 recall records (1 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 5 recall records (1 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202510000
202400000
202300000
202200051
202100030
202010040
201900051
201810070
201700010

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Jubilant Cadista Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Jubilant Cadista Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

31 recall records from Feb 11, 2013 to Dec 27, 2022. Showing the 20 most recent. View all 31 recall records

NumberClassProductDate
D-0096-2023Class IIIProchlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals…Dec 27, 2022
D-1294-2022Class IIIrbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd…Jul 18, 2022
D-1293-2022Class IIIrbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd…Jul 18, 2022
D-0752-2022Class IIIMethylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista…Apr 1, 2022
D-0767-2022Class IMeclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle)…Mar 8, 2022
D-0784-2021Class IIIDonepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd…Aug 20, 2021
D-0333-2021Class IIItraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd…Apr 1, 2021
D-0298-2021Class IIIMethylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista…Feb 19, 2021
D-0104-2021Class IIclomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant…Nov 6, 2020
D-0066-2021Class IIIOlanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only…Oct 26, 2020
D-1281-2020Class IIILamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista…May 26, 2020
D-1058-2020Class IIPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by…Mar 11, 2020
D-0576-2020Class IIAmantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant…Dec 2, 2019
D-0145-2020Class IIPantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only…Sep 4, 2019
D-1837-2019Class IDrospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3…Jul 9, 2019
D-1074-2019Class IIPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by…Mar 29, 2019
D-0519-2019Class IIIBuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) &…Feb 28, 2019
D-0011-2019Class IIPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by…Oct 2, 2018
D-1205-2018Class IIIMethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista…Aug 27, 2018
D-1103-2018Class IIIValsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd…Aug 14, 2018

Recent FDA inspections

9 inspections from Oct 29, 2009 to Jan 15, 2025.

DateSiteProductClassificationFEI
Jan 15, 2025Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
Feb 28, 2020Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
May 4, 2018Yardley, PADrugsNo Action Indicated (NAI)3017221809
Aug 7, 2015Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
Jul 8, 2014Yardley, PADrugsNo Action Indicated (NAI)3017221809
Aug 1, 2013Yardley, PADrugsNo Action Indicated (NAI)3017221809
Apr 5, 2012Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
Mar 23, 2011Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
Oct 29, 2009Yardley, PADrugsVoluntary Action Indicated (VAI)3017221809
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3017221809Yardley, PA9Jan 15, 2025

Jubilant Cadista Pharmaceuticals, Inc. and the FDA: common questions

Has Jubilant Cadista Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Jubilant Cadista Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Jubilant Cadista Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Jubilant Cadista Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Jubilant Cadista Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Jan 15, 2025 at Yardley, PA and was classified VAI. FDA has 9 inspections of Jubilant Cadista Pharmaceuticals, Inc. on file.

Has Jubilant Cadista Pharmaceuticals, Inc. had an FDA recall?

Yes. Jubilant Cadista Pharmaceuticals, Inc. has 31 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Dec 27, 2022.

Need more than this page shows? Ask about Jubilant Cadista Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.